Crystallization R&D
Headed by science-centric subject matter experts, the Crystallization R&D is recognized as an industry preferred partner in solid form screening and selection, crystallization process development, pre-formulation, particle engineering and Drug Substance (DS) Drug Product (DP) co-processing. Applying over 200 years of cumulative experience in globally recognized large pharma and CRO, our subject matter experts and scientists take pride in offering effective solutions to CMC challenges in solid form and crystallization process. The solutions offered are scientifically driven with a dedication to the mechanistic understanding of the fundamentals. Our dedicated scientists pay great attention to understanding your project’s needs and constraints. We utilize our expertise and experience to deliver specific solutions appropriate to the phase of development.
What we can offer:
- Solid form screening and selection
- Solid state characterization
- Single crystal structure elucidation
- Crystallization process development
- Pre-formulation evaluation
- Particle engineering
- Drug Substance (DS) – Drug Product (DP) co-processing
- Solid state risk assessment for DS & DP
